{"id":491482,"date":"2010-03-30T23:30:10","date_gmt":"2010-03-31T03:30:10","guid":{"rendered":"http:\/\/kempton.wordpress.com\/?p=10639"},"modified":"2010-03-30T23:30:10","modified_gmt":"2010-03-31T03:30:10","slug":"brca1-brca2-test-for-breast-ovarian-cancers-ruled-not-patentable-by-us-federal-district-court-in-manhattan","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/491482","title":{"rendered":"BRCA1 &amp; BRCA2 test for breast &amp; ovarian cancers ruled not patentable by US Federal District Court in Manhattan"},"content":{"rendered":"<p>From Business Week, &#8220;<strong><a title=\"http:\/\/www.businessweek.com\/ap\/financialnews\/D9EP20LO0.htm\" href=\"http:\/\/www.businessweek.com\/ap\/financialnews\/D9EP20LO0.htm\" >Myriad Genetics falls as gene patents are voided<\/a><\/strong>&#8220;,<\/p>\n<blockquote>\n<p>&#8220;[&#8230;] a court overturned a group of patents on gene sequences linked to breast cancer and ovarian cancer, which Myriad uses in tests for those diseases.<\/p>\n<p>Myriad Genetics sells a test for mutations on the two breast cancer predisposition genes, which are called <strong><a title=\"http:\/\/www.cancer.gov\/cancertopics\/factsheet\/Risk\/BRCA\" href=\"http:\/\/www.cancer.gov\/cancertopics\/factsheet\/Risk\/BRCA\" >BRCA1 and BRCA2<\/a><\/strong>, and says those mutations are connected to greatly increased risks of cancer. The company holds patents on several DNA sequences from the gene, but its patents were challenged a year ago in a lawsuit by the American Civil Liberties Union and other groups. On Monday, a U.S. District Court Judge ruled against the Myriad Genetics.&#8221;<\/p>\n<\/blockquote>\n<p>More info from the <strong><a title=\"http:\/\/en.wikipedia.org\/wiki\/Gene_patent\" href=\"http:\/\/en.wikipedia.org\/wiki\/Gene_patent\" >gene patent page at Wikipedia<\/a><\/strong>.<\/p>\n<p>Filed under: <a href='http:\/\/kempton.wordpress.com\/category\/health-sciences-medicine\/'>Health Sciences &amp; Medicine<\/a>, <a href='http:\/\/kempton.wordpress.com\/category\/patent\/'>patent<\/a>  <a rel=\"nofollow\" href=\"http:\/\/feeds.wordpress.com\/1.0\/gocomments\/kempton.wordpress.com\/10639\/\"><img decoding=\"async\" alt=\"\" border=\"0\" src=\"http:\/\/feeds.wordpress.com\/1.0\/comments\/kempton.wordpress.com\/10639\/\" \/><\/a> <a rel=\"nofollow\" href=\"http:\/\/feeds.wordpress.com\/1.0\/godelicious\/kempton.wordpress.com\/10639\/\"><img decoding=\"async\" alt=\"\" border=\"0\" src=\"http:\/\/feeds.wordpress.com\/1.0\/delicious\/kempton.wordpress.com\/10639\/\" \/><\/a> <a rel=\"nofollow\" href=\"http:\/\/feeds.wordpress.com\/1.0\/gostumble\/kempton.wordpress.com\/10639\/\"><img decoding=\"async\" alt=\"\" border=\"0\" src=\"http:\/\/feeds.wordpress.com\/1.0\/stumble\/kempton.wordpress.com\/10639\/\" \/><\/a> <a rel=\"nofollow\" href=\"http:\/\/feeds.wordpress.com\/1.0\/godigg\/kempton.wordpress.com\/10639\/\"><img decoding=\"async\" alt=\"\" border=\"0\" src=\"http:\/\/feeds.wordpress.com\/1.0\/digg\/kempton.wordpress.com\/10639\/\" \/><\/a> <a rel=\"nofollow\" href=\"http:\/\/feeds.wordpress.com\/1.0\/goreddit\/kempton.wordpress.com\/10639\/\"><img decoding=\"async\" alt=\"\" border=\"0\" src=\"http:\/\/feeds.wordpress.com\/1.0\/reddit\/kempton.wordpress.com\/10639\/\" \/><\/a> <img decoding=\"async\" alt=\"\" border=\"0\" src=\"http:\/\/stats.wordpress.com\/b.gif?host=kempton.wordpress.com&#038;blog=364107&#038;post=10639&#038;subd=kempton&#038;ref=&#038;feed=1\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>From Business Week, &#8220;Myriad Genetics falls as gene patents are voided&#8220;, &#8220;[&#8230;] a court overturned a group of patents on gene sequences linked to breast cancer and ovarian cancer, which Myriad uses in tests for those diseases. Myriad Genetics sells a test for mutations on the two breast cancer predisposition genes, which are called BRCA1 [&hellip;]<\/p>\n","protected":false},"author":841,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-491482","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/491482","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/841"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=491482"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/491482\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=491482"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=491482"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=491482"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}